2m 2m 2m 2m 2m 2m 2m
NRX PHARMA (NRXP)
NASDAQ
$3.27+$0.12 (+3.65%)
Price as of Aug 03, 2026 10:21 AM EDT- $134.8MMarket Cap
- 21.62%1-Year Change
- BiotechnologyIndustry
NRX PHARMA (NRXP)
$3.27+$0.12 (+3.65%)
NRXP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.15 | ||
Change | +$0.03 (+0.96%) | ||
Open | $3.16 | ||
High | $3.30 | ||
Low | $2.95 | ||
Previous Close | $3.12 | ||
Volume | 1,147,529 | ||
30-Day Average Volume | 861,399 | ||
1-Week Change | -16.00% | ||
1-Month Change | -22.98% | ||
1-Year Change | 21.62% | ||
3-Year Change | -19.25% | ||
5-Year Change | -97.92% | ||
Fundamentals | |||
Shares Outstanding | 42.8M | ||
Total Assets | $11.9M | ||
Market Cap | $134.8M | ||
Enterprise Value | $128.1M | ||
Period: QTR TTM FY | |||
Revenue | $1.1M | ||
Net Income | -$1.4M | ||
Free Cash Flow | -$4.3M | ||
EBIT | -$1.4M | ||
EBITDA | -$1.4M | ||
Net Working Capital | -$17.8M | ||
EPS | -$0.04 | ||
Enterprise Value/EBITDA | -94 | ||
Enterprise Value/Revenue | 120 | ||
P/B | -10 | ||
P/E | -79 | ||
PEG | -1 | ||
Price/Free Cash Flow | -31 | ||
Price/Operating Cash Flow | -31 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 04/02/2024 | ||
Earnings & Revenue